This article is a correction to:
Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
Jiří Plášek1,2*
Jozef Dodulík1Marie Lazárová1
David Stejskal3,4Zdeněk Švagera3,4
Nela Chobolová3Patrik Šulc1Lukáš Evin1,2
Dana Purová5Jan Václavík1,2
- 1Department of Internal Medicine and Cardiology, University Hospital Ostrava, Ostrava, Czechia
- 2Research Center for Internal and Cardiovascular Diseases Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 3Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czechia
- 4Institute of Laboratory Medicine, University of Ostrava, Ostrava, Czechia
- 5Social Health Institute, Palacky University Olomouc, Olomouc, Czechia
A Corrigendum on
By Plášek J, Dodulík J, Lazárová M, Stejskal D, Švagera Z, Chobolová N, Šulc P, Evin L, Purová D and Václavík J. (2023). Front. Cardiovasc. Med. doi: 10.3389/fcvm.2023.1297900
In the published article, there were multiple errors in Table 2 as published. The values in Table 2 as seen below have been corrected.
Table 2
Table 2. Baseline characteristics of the healthy volunteers.
The corrected Table 2 and its caption appear below.
Table 2
Table 2. Baseline characteristics of the healthy volunteers.
The authors apologize for this errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
In the published article, there was an error in assumptions about differences in males and females in the healthy volunteers group.
A correction has been made to Results. This sentence previously stated:
“Males and females in the healthy individuals group differed in anthropometric parameters, plasma creatinine level, hs-CRP, and thrombocyte count (Table 2)”.
The corrected sentence appears below:
“Males and females in the healthy individuals’ group did not differ in any parameters (Table 2)”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: secretoneurin, heart failure, CaMKII, dilated cardiomyopathy, ischaemic cardiomyopathy
Citation: Plášek J, Dodulík J, Lazárová M, Stejskal D, Švagera Z, Chobolová N, Šulc P, Evin L, Purová D and Václavík J (2024) Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results. Front. Cardiovasc. Med. 11:1392484. doi: 10.3389/fcvm.2024.1392484
Received: 27 February 2024; Accepted: 19 March 2024;
Published: 3 April 2024.
Edited and Reviewed by: Matteo Cameli, University of Siena, Italy
© 2024 Plášek, Dodulík, Lazárová, Stejskal, Švagera, Chobolová, Šulc, Evin, Purová and Václavík. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiří Plášek jiri.plasek@fno.cz